Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-25-045733
Filing Date
2025-03-04
Accepted
2025-03-04 17:19:40
Documents
8

Document Format Files

Seq Description Document Type Size
1 POS AM d888362dposam.htm POS AM 193958
2 EX-5.1 d888362dex51.htm EX-5.1 16787
3 EX-23.1 d888362dex231.htm EX-23.1 1605
4 EX-FILING FEES d888362dexfilingfees.htm EX-FILING FEES 47680
5 GRAPHIC g888362dsp22.jpg GRAPHIC 7697
6 GRAPHIC g888362g0301005231652.jpg GRAPHIC 1502
7 GRAPHIC g888362g0301005231788.jpg GRAPHIC 5926
8 GRAPHIC g888362g0301005231893.jpg GRAPHIC 4509
  Complete submission text file 0001193125-25-045733.txt   288702
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-283150 | Film No.: 25706460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)